Starting from these studies, the same authors synthesized a large library of compounds with very potent action on B-cell lymphomas (Ramos and Jeko-1) and Daudi cell lines with high BTK expression. The gene discussed is BTK; the disease is B-cell non-Hodgkin lymphoma.